Cite

HARVARD Citation

    Bossuyt, V. et al. (2020). Pathologic evaluation of response to neoadjuvant therapy drives treatment changes and improves long‐term outcomes for breast cancer patients. Breast journal. 26 (6), pp. 1189-1198. [Online]. 
  
Back to record